Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin and Pemetrexed in Stage IIIB/IV Nonsquamous NSCLC
NCT01126736Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Countries
- 5
01
Overview
A Phase 2 trial of eribulin in non-small cell lung cancer (NSCLC), sponsored by Eisai Co., Ltd.. Started Jun 2010; status: completed.
02
Drugs
eribulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01126736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01126736.